The Chk1/Cdc25A pathway as activators of the cell cycle in neuronal death induced by camptothecin.
Cell cycle regulators appear to play a paradoxical role in neuronal death. We have shown previously that cyclin-dependent kinases (CDKs), along with their downstream effectors, Rb (retinoblastoma) and E2F/DP1 (E2 promoter binding factor/deleted in polyposis 1), regulate neuronal death evoked by the DNA damaging agent camptothecin. However, the mechanism by which CDKs are activated in this model is unclear. The cell division cycle 25A (Cdc25A) phosphatase is a critical regulator of cell cycle CDKs in proliferating cells. In cortical neurons, we presently show that expression of Cdc25A promotes death even in the absence of DNA damage. Importantly, Cdc25A activity is rapidly increased during DNA damage treatment. Inhibition of Cdc25A blocks death and reduces cyclin D1-associated kinase activity and Rb phosphorylation. This indicates that endogenous Cdc25A activity is important for regulation of cell cycle-mediated neuronal death. We also examined how Cdc25A activity is regulated after DNA damage. Cultured embryonic cortical neurons have a significant basal activity of checkpoint kinase 1 (Chk1), a kinase that regulates cell cycle arrest. During camptothecin treatment of neurons, this activity is rapidly downregulated with a concomitant increase in Cdc25A activity. Importantly, expression of wild-type Chk1, but not kinase-dead Chk1, inhibits the camptothecin-induced increase in Cdc25A activity. In addition, Chk1 expression also promotes survival in the presence of the DNA-damaging agent. Together, our data suggest that a Chk1/Cdc25A activity participates in activation of a cell cycle pathway-mediated death signal in neurons. These data also define how a proliferative signal may be abnormally activated in a postmitotic environment.
Zhang
Yi
Y
Ottawa Health Research Institute, Neuroscience Group, University of Ottawa, Ottawa, Ontario, Canada, K1H 8M5.
Qu
Dianbo
D
Morris
Erick J
EJ
O'Hare
Michael J
MJ
Callaghan
Steven M
SM
Slack
Ruth S
RS
Geller
Herbert M
HM
Park
David S
DS
D000818:Animals; D017209:Apoptosis / Q000502:physiology*; D002166:Camptothecin / Q000494:pharmacology*; D002453:Cell Cycle / Q000502:physiology*; D002478:Cells, Cultured; D000071877:Checkpoint Kinase 1; D018844:Cyclin-Dependent Kinases / Q000378:metabolism; D004249:DNA Damage; D051379:Mice; D008815:Mice, Inbred Strains; D009474:Neurons / Q000166:cytology* / Q000187:drug effects / Q000378:metabolism*; D011494:Protein Kinases / Q000378:metabolism* / Q000502:physiology; D034622:RNA Interference; D020687:cdc25 Phosphatases / Q000037:antagonists & inhibitors / Q000235:genetics / Q000378:metabolism*
D011494:Protein Kinases; D000071877:Checkpoint Kinase 1; C000605869:Chek1 protein, mouse; D018844:Cyclin-Dependent Kinases; C517005:Cdc25a protein, mouse; D020687:cdc25 Phosphatases; D002166:Camptothecin